Braintact Company Profile
This profile of BRAINTACT LTD is based on multiple public records. It may contain errors, and certainly contains omissions. You can help fill in the gaps.
Website: EDIT
Basics
Annual revenue: $0 EDIT
Annual profit: EDIT
No. of employees: 0 EDIT
Parent company: BRAINTACT LTD EDIT
Related company names: BRAINTACT LTD EDIT
Top military customer: EDIT
Aggregate value of contracts from top customer in years _:
Number of contracts represented in that total:
Locations
SOURCE EDIT LOCATIONS
People
**
Top owner (individual)**: SOURCE EDIT EDIT MUGSHOT
Top owner (institutional): EDIT
Other owners: EDIT
**
Chief executive: Noa Shelach SOURCE EDIT EDIT MUGSHOT
Chief executive annual compensation**: EDIT
Other executives: EDIT
**
Board chair**: EDIT EDIT MUGSHOT
Other board members: EDIT
**
Top lobbyist**: EDIT EDIT MUGSHOT
Other lobbyists: EDIT
Annual lobbying expenses (average or most recent year): EDIT
**
Top political donee: EDIT EDIT MUGSHOT
Lifetime total given to top donee**:
Other political donees: EDIT
Annual political campaign giving (average or most recent year): EDIT
Associated people: EDIT
Activities
Braintact develops a novel drug for the treatment of acute and chronic neurodegenerative disorders based on Prof. TeichbergÕs innovative, patent pending blood glutamate scavenging system.
Original record type: , 2009
Last updated on Feb. 25, 2011 with contributions from WIB.